Back
Edwards Lifesciences Corporatio (EW)
Health CareEW · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$95.18
+0.86%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$1.83
ROE
10.5%
Gross margin
77.9%
Debt/Equity
6.81x
Revenue growth
16.7%
Edwards Lifesciences Corporatio — company intelligence
Earnings surprises
Q1 2026$0.78 vs $0.75 est+4.2%
Q4 2025$0.58 vs $0.64 est-8.8%
Q3 2025$0.67 vs $0.61 est+9.6%
Q2 2025$0.67 vs $0.64 est+4.4%
Analyst consensus · 42 analysts
31 Buy11 Hold0 Sell
Updated Jul 5, 2026
Insider activity · 90 days
25 buys37 sellsnet +397,412 shares
Lippis Daniel J.Sell 377 · Jul 7, 2026
Zovighian Bernard JSell 523 · Jun 17, 2026
Dahl Andrew M.Sell 568 · May 29, 2026
Recent SEC filings
4 — Insider transaction reportJul 7, 2026
4 — Insider transaction reportJun 30, 2026
4 — Insider transaction reportJun 17, 2026
Latest news
Evercore ISI Group Maintains Outperform on Edwards Lifesciences, Raises Price Target to $100 — Benzinga · 4d ago
BTIG Maintains Buy on Edwards Lifesciences, Raises Price Target to $110 — Benzinga · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Edwards Lifesciences Corporatio
Weekly undervalued picks (like EW)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.